Stay updated on Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision label v3.6.5 appears in the version history, replacing the previous v3.6.4.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study record history now shows a new revision entry (v3.6.4) replacing the previous (v3.6.3), indicating an update to the page's version history. This is a minor metadata update that tracks the latest revision of the record.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now includes a new Revision: v3.6.3 entry and removes the previous Revision: v3.6.2 entry. This updates the version history to reflect the latest release label.SummaryDifference0.1%

- Check55 days agoChange DetectedA new latest revision, v3.6.2, is added to the history and the previous v3.6.0 entry is removed, indicating a minor backend update to the page’s record-keeping.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment status updated to 'No longer looking for participants.' The record revision advanced to v3.6.0, replacing the previous v3.5.5 revision.SummaryDifference0.3%

- Check77 days agoChange DetectedThe history entry is updated to v3.5.5, replacing the previous v3.5.4, representing a minor software/UI update to the page rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Epacadostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epacadostat in Melanoma Clinical Trial page.